Lonza Signs Agreement with Index Ventures for Biological Products - - BioPharm International

ADVERTISEMENT

Lonza Signs Agreement with Index Ventures for Biological Products



Lonza, a custom biologics manufacturing organization and Index Ventures, a venture capital investment firm, have signed an agreement for process development and cGMP production for all biological products in the portfolio of companies where Index is the major investor. Over the course of the agreement, additional development and manufacturing projects will be added to the product list, as future investments are made by Index.

Source: Lonza

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Lilly to Acquire Novartis Animal Health
April 22, 2014
Novartis and GSK Trade Assets
April 22, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Author Guidelines

Click here